CellSource Co Ltd
TSE:4880

Watchlist Manager
CellSource Co Ltd Logo
CellSource Co Ltd
TSE:4880
Watchlist
Price: 1 096 JPY -3.69%
Market Cap: 21.7B JPY
Have any thoughts about
CellSource Co Ltd?
Write Note

CellSource Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellSource Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
CellSource Co Ltd
TSE:4880
Interest Income Expense
ÂĄ23m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CMIC Holdings Co Ltd
TSE:2309
Interest Income Expense
ÂĄ3.6B
CAGR 3-Years
229%
CAGR 5-Years
N/A
CAGR 10-Years
60%
C
Chiome Bioscience Inc
TSE:4583
Interest Income Expense
-ÂĄ1.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Precision System Science Co Ltd
TSE:7707
Interest Income Expense
-ÂĄ50.6m
CAGR 3-Years
-69%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Medinet Co Ltd
TSE:2370
Interest Income Expense
ÂĄ41.6m
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
-21%
WDB coco Co Ltd
TSE:7079
Interest Income Expense
-ÂĄ109k
CAGR 3-Years
-26%
CAGR 5-Years
-122%
CAGR 10-Years
N/A
No Stocks Found

CellSource Co Ltd
Glance View

Market Cap
21.7B JPY
Industry
Life Sciences Tools & Services

CellSource Co., Ltd. engages in regenerative medicine related business. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 90 full-time employees. The company went IPO on 2019-10-28. The firm operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.

Intrinsic Value
969.93 JPY
Overvaluation 12%
Intrinsic Value
Price

See Also

What is CellSource Co Ltd's Interest Income Expense?
Interest Income Expense
23m JPY

Based on the financial report for Oct 31, 2023, CellSource Co Ltd's Interest Income Expense amounts to 23m JPY.

What is CellSource Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
32%

Over the last year, the Interest Income Expense growth was 32%.

Back to Top